The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study.
Vasey MJ., Tai XY., Thorpe J., Jones GD., Ashby S., Hallab A., Ding D., Andraus M., Dugan P., Perucca P., Costello DJ., French JA., O'Brien TJ., Depondt C., Andrade DM., Sengupta R., Datta A., Delanty N., Jette N., Newton CR., Brodie MJ., Devinsky O., Cross JH., Sander JW., Hanna J., Besag FMC., Sen A., COVID‐19 Epilepsy COV‐E Study Group None.
OBJECTIVE: To characterize the experience of people with epilepsy and aligned healthcare workers (HCWs) during the first 18 months of the COVID-19 pandemic and compare experiences in high-income countries (HICs) with non-HICs. METHODS: Separate surveys for people with epilepsy and HCWs were distributed online in April 2020. Responses were collected to September 2021. Data were collected for COVID-19 infections, the effect of COVID-related restrictions, access to specialist help for epilepsy (people with epilepsy), and the impact of the pandemic on work productivity (HCWs). The frequency of responses for non-HICs and HICs were compared using non-parametric Chi-square tests. RESULTS: Two thousand one hundred and five individuals with epilepsy from 53 countries and 392 HCWs from 26 countries provided data. The same proportion of people with epilepsy in non-HICs and HICs reported COVID-19 infection (7%). Those in HICs were more likely to report that COVID-19 measures had affected their health (32% vs. 23%; p